The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Artemisunate Market Research Report 2024
Synopsis
The global Artemisunate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Artemisunate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Artemisunate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Artemisunate include Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical, Shanghai Natural Bio-engineering Co, Novanat Bioresource and Botanical Extracts EPZ Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Artemisunate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artemisunate.
Report Scope
The Artemisunate market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artemisunate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artemisunate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
KPC Pharmaceuticals
Guangxi Xiancaotang Pharmaceutical
Guilin Pharmaceutical
Kerui Nanhai Pharmaceutical
Shanghai Natural Bio-engineering Co
Novanat Bioresource
Botanical Extracts EPZ Ltd
Segment by Type
Pharmaceutical Grade
Industrial Grade
Segment by Application
Malaria Treatment
Scientific Research
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artemisunate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Artemisunate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Artemisunate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The global Artemisunate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Artemisunate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Artemisunate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Artemisunate include Sanofi, KPC Pharmaceuticals, Guangxi Xiancaotang Pharmaceutical, Guilin Pharmaceutical, Kerui Nanhai Pharmaceutical, Shanghai Natural Bio-engineering Co, Novanat Bioresource and Botanical Extracts EPZ Ltd, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Artemisunate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artemisunate.
Report Scope
The Artemisunate market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artemisunate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artemisunate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
KPC Pharmaceuticals
Guangxi Xiancaotang Pharmaceutical
Guilin Pharmaceutical
Kerui Nanhai Pharmaceutical
Shanghai Natural Bio-engineering Co
Novanat Bioresource
Botanical Extracts EPZ Ltd
Segment by Type
Pharmaceutical Grade
Industrial Grade
Segment by Application
Malaria Treatment
Scientific Research
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artemisunate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Artemisunate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Artemisunate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Artemisunate Market Overview
1.1 Product Definition
1.2 Artemisunate Segment by Type
1.2.1 Global Artemisunate Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Pharmaceutical Grade
1.2.3 Industrial Grade
1.3 Artemisunate Segment by Application
1.3.1 Global Artemisunate Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Malaria Treatment
1.3.3 Scientific Research
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Artemisunate Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Artemisunate Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Artemisunate Production Estimates and Forecasts (2019-2030)
1.4.4 Global Artemisunate Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Artemisunate Production Market Share by Manufacturers (2019-2024)
2.2 Global Artemisunate Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Artemisunate, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Artemisunate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Artemisunate Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Artemisunate, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Artemisunate, Product Offered and Application
2.8 Global Key Manufacturers of Artemisunate, Date of Enter into This Industry
2.9 Artemisunate Market Competitive Situation and Trends
2.9.1 Artemisunate Market Concentration Rate
2.9.2 Global 5 and 10 Largest Artemisunate Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Artemisunate Production by Region
3.1 Global Artemisunate Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Artemisunate Production Value by Region (2019-2030)
3.2.1 Global Artemisunate Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Artemisunate by Region (2025-2030)
3.3 Global Artemisunate Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Artemisunate Production by Region (2019-2030)
3.4.1 Global Artemisunate Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Artemisunate by Region (2025-2030)
3.5 Global Artemisunate Market Price Analysis by Region (2019-2024)
3.6 Global Artemisunate Production and Value, Year-over-Year Growth
3.6.1 North America Artemisunate Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Artemisunate Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Artemisunate Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Artemisunate Production Value Estimates and Forecasts (2019-2030)
4 Artemisunate Consumption by Region
4.1 Global Artemisunate Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Artemisunate Consumption by Region (2019-2030)
4.2.1 Global Artemisunate Consumption by Region (2019-2024)
4.2.2 Global Artemisunate Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Artemisunate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Artemisunate Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Artemisunate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Artemisunate Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Artemisunate Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Artemisunate Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Artemisunate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Artemisunate Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Artemisunate Production by Type (2019-2030)
5.1.1 Global Artemisunate Production by Type (2019-2024)
5.1.2 Global Artemisunate Production by Type (2025-2030)
5.1.3 Global Artemisunate Production Market Share by Type (2019-2030)
5.2 Global Artemisunate Production Value by Type (2019-2030)
5.2.1 Global Artemisunate Production Value by Type (2019-2024)
5.2.2 Global Artemisunate Production Value by Type (2025-2030)
5.2.3 Global Artemisunate Production Value Market Share by Type (2019-2030)
5.3 Global Artemisunate Price by Type (2019-2030)
6 Segment by Application
6.1 Global Artemisunate Production by Application (2019-2030)
6.1.1 Global Artemisunate Production by Application (2019-2024)
6.1.2 Global Artemisunate Production by Application (2025-2030)
6.1.3 Global Artemisunate Production Market Share by Application (2019-2030)
6.2 Global Artemisunate Production Value by Application (2019-2030)
6.2.1 Global Artemisunate Production Value by Application (2019-2024)
6.2.2 Global Artemisunate Production Value by Application (2025-2030)
6.2.3 Global Artemisunate Production Value Market Share by Application (2019-2030)
6.3 Global Artemisunate Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Sanofi
7.1.1 Sanofi Artemisunate Corporation Information
7.1.2 Sanofi Artemisunate Product Portfolio
7.1.3 Sanofi Artemisunate Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Sanofi Main Business and Markets Served
7.1.5 Sanofi Recent Developments/Updates
7.2 KPC Pharmaceuticals
7.2.1 KPC Pharmaceuticals Artemisunate Corporation Information
7.2.2 KPC Pharmaceuticals Artemisunate Product Portfolio
7.2.3 KPC Pharmaceuticals Artemisunate Production, Value, Price and Gross Margin (2019-2024)
7.2.4 KPC Pharmaceuticals Main Business and Markets Served
7.2.5 KPC Pharmaceuticals Recent Developments/Updates
7.3 Guangxi Xiancaotang Pharmaceutical
7.3.1 Guangxi Xiancaotang Pharmaceutical Artemisunate Corporation Information
7.3.2 Guangxi Xiancaotang Pharmaceutical Artemisunate Product Portfolio
7.3.3 Guangxi Xiancaotang Pharmaceutical Artemisunate Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Guangxi Xiancaotang Pharmaceutical Main Business and Markets Served
7.3.5 Guangxi Xiancaotang Pharmaceutical Recent Developments/Updates
7.4 Guilin Pharmaceutical
7.4.1 Guilin Pharmaceutical Artemisunate Corporation Information
7.4.2 Guilin Pharmaceutical Artemisunate Product Portfolio
7.4.3 Guilin Pharmaceutical Artemisunate Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Guilin Pharmaceutical Main Business and Markets Served
7.4.5 Guilin Pharmaceutical Recent Developments/Updates
7.5 Kerui Nanhai Pharmaceutical
7.5.1 Kerui Nanhai Pharmaceutical Artemisunate Corporation Information
7.5.2 Kerui Nanhai Pharmaceutical Artemisunate Product Portfolio
7.5.3 Kerui Nanhai Pharmaceutical Artemisunate Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Kerui Nanhai Pharmaceutical Main Business and Markets Served
7.5.5 Kerui Nanhai Pharmaceutical Recent Developments/Updates
7.6 Shanghai Natural Bio-engineering Co
7.6.1 Shanghai Natural Bio-engineering Co Artemisunate Corporation Information
7.6.2 Shanghai Natural Bio-engineering Co Artemisunate Product Portfolio
7.6.3 Shanghai Natural Bio-engineering Co Artemisunate Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Shanghai Natural Bio-engineering Co Main Business and Markets Served
7.6.5 Shanghai Natural Bio-engineering Co Recent Developments/Updates
7.7 Novanat Bioresource
7.7.1 Novanat Bioresource Artemisunate Corporation Information
7.7.2 Novanat Bioresource Artemisunate Product Portfolio
7.7.3 Novanat Bioresource Artemisunate Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Novanat Bioresource Main Business and Markets Served
7.7.5 Novanat Bioresource Recent Developments/Updates
7.8 Botanical Extracts EPZ Ltd
7.8.1 Botanical Extracts EPZ Ltd Artemisunate Corporation Information
7.8.2 Botanical Extracts EPZ Ltd Artemisunate Product Portfolio
7.8.3 Botanical Extracts EPZ Ltd Artemisunate Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Botanical Extracts EPZ Ltd Main Business and Markets Served
7.7.5 Botanical Extracts EPZ Ltd Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Artemisunate Industry Chain Analysis
8.2 Artemisunate Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Artemisunate Production Mode & Process
8.4 Artemisunate Sales and Marketing
8.4.1 Artemisunate Sales Channels
8.4.2 Artemisunate Distributors
8.5 Artemisunate Customers
9 Artemisunate Market Dynamics
9.1 Artemisunate Industry Trends
9.2 Artemisunate Market Drivers
9.3 Artemisunate Market Challenges
9.4 Artemisunate Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
